Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	KRAB	ZNF527 ZNF184 ZNF213 ZNF688 ZNF785 ZNF394 ZNF615 ZNF649 ZNF584 ZNF689 ZKSCAN2 ZNF181 ZNF2 ZSCAN20 ZNF764 ZNF667 ZNF747 ZNF554	1.14e-07	369	202	18	SM00349
Domain	KRAB	ZNF527 ZNF184 ZNF213 ZNF688 ZNF785 ZNF394 ZNF615 ZNF649 ZNF584 ZNF689 ZKSCAN2 ZNF181 ZNF2 ZSCAN20 ZNF764 ZNF667 ZNF747 ZNF554	1.19e-07	370	202	18	IPR001909
Domain	Chromo_domain	CBX3 CBX1 CHD6 CHD9 CHD8 CHD7	1.70e-07	24	202	6	IPR023780
Domain	BRK	CHD6 CHD9 CHD8 CHD7	1.96e-07	6	202	4	SM00592
Domain	BRK_domain	CHD6 CHD9 CHD8 CHD7	1.96e-07	6	202	4	IPR006576
Domain	BRK	CHD6 CHD9 CHD8 CHD7	1.96e-07	6	202	4	PF07533
Domain	Chromo	CBX3 CBX1 CHD6 CHD9 CHD8 CHD7	2.86e-07	26	202	6	PF00385
Domain	KRAB	ZNF527 ZNF184 ZNF213 ZNF688 ZNF785 ZNF394 ZNF615 ZNF649 ZNF584 ZNF689 ZKSCAN2 ZNF181 ZNF2 ZNF764 ZNF667 ZNF747 ZNF554	3.81e-07	358	202	17	PS50805
Domain	KRAB	ZNF527 ZNF184 ZNF213 ZNF688 ZNF785 ZNF394 ZNF615 ZNF649 ZNF584 ZNF689 ZKSCAN2 ZNF181 ZNF2 ZNF764 ZNF667 ZNF747 ZNF554	3.81e-07	358	202	17	PF01352
Domain	CHROMO_1	CBX3 CBX1 CHD6 CHD9 CHD8 CHD7	4.59e-07	28	202	6	PS00598
Domain	CHROMO_2	CBX3 CBX1 CHD6 CHD9 CHD8 CHD7	4.59e-07	28	202	6	PS50013
Domain	Chromodomain-like	CBX3 CBX1 CHD6 CHD9 CHD8 CHD7	1.07e-06	32	202	6	IPR016197
Domain	Chromo/shadow_dom	CBX3 CBX1 CHD6 CHD9 CHD8 CHD7	1.29e-06	33	202	6	IPR000953
Domain	CHROMO	CBX3 CBX1 CHD6 CHD9 CHD8 CHD7	1.29e-06	33	202	6	SM00298
Domain	WD_REPEATS_1	COPB2 NWD2 CDC40 BRWD1 WDPCP DENND3 SCAP WDHD1 WDR97 TLE6 WDR12 WDSUB1	5.25e-05	278	202	12	PS00678
Domain	WD_REPEATS_2	COPB2 NWD2 CDC40 BRWD1 WDPCP DENND3 SCAP WDHD1 WDR97 TLE6 WDR12 WDSUB1	5.44e-05	279	202	12	PS50082
Domain	WD_REPEATS_REGION	COPB2 NWD2 CDC40 BRWD1 WDPCP DENND3 SCAP WDHD1 WDR97 TLE6 WDR12 WDSUB1	5.44e-05	279	202	12	PS50294
Domain	WD40_repeat_CS	NWD2 CDC40 BRWD1 DENND3 SCAP WDHD1 WDR97 WDR12 WDSUB1	7.57e-05	164	202	9	IPR019775
Domain	WD40_repeat_dom	COPB2 NWD2 CDC40 BRWD1 WDPCP DENND3 SCAP WDHD1 WDR97 TLE6 WDR12 WDSUB1	9.87e-05	297	202	12	IPR017986
Domain	ACTININ_2	SPTBN2 DST FLNA FLNB	1.00e-04	23	202	4	PS00020
Domain	ACTININ_1	SPTBN2 DST FLNA FLNB	1.00e-04	23	202	4	PS00019
Domain	Actinin_actin-bd_CS	SPTBN2 DST FLNA FLNB	1.00e-04	23	202	4	IPR001589
Domain	-	ZNF527 ZNF184 ZNF213 ZNF688 ZNF785 ZNF394 ZNF615 ZNF579 ZNF649 ZNF584 ZNF689 ZKSCAN2 ZNF181 ZNF2 ZSCAN20 KLF1 ZNF764 ZNF667 ZNF554	1.51e-04	679	202	19	3.30.160.60
Domain	Znf_C2H2-like	ZNF527 DZIP1L ZNF184 ZNF213 ZNF688 ZNF785 ZNF394 ZNF615 ZNF579 ZNF649 ZNF584 ZNF689 ZKSCAN2 ZNF181 ZNF2 ZSCAN20 KLF1 ZNF764 ZNF667 DHX34 ZNF554	1.53e-04	796	202	21	IPR015880
Domain	WD40	COPB2 NWD2 CDC40 BRWD1 DENND3 SCAP WDHD1 WDR97 TLE6 WDR12 WDSUB1	1.68e-04	268	202	11	SM00320
Domain	ZnF_C2H2	ZNF527 DZIP1L ZNF184 ZNF213 ZNF688 ZNF785 ZNF394 ZNF615 ZNF579 ZNF649 ZNF584 ZNF689 ZKSCAN2 ZNF181 ZNF2 ZSCAN20 KLF1 ZNF764 ZNF667 DHX34 ZNF554	1.87e-04	808	202	21	SM00355
Domain	WD40_repeat	COPB2 NWD2 CDC40 BRWD1 DENND3 SCAP WDHD1 WDR97 TLE6 WDR12 WDSUB1	1.91e-04	272	202	11	IPR001680
Domain	zf-C2H2	ZNF527 ZNF184 ZNF213 ZNF688 ZNF785 ZNF394 ZNF615 ZNF579 ZNF649 ZNF584 ZNF689 ZKSCAN2 ZNF181 ZNF2 ZSCAN20 KLF1 ZNF764 ZNF667 ZNF554	1.96e-04	693	202	19	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF527 ZNF184 ZNF213 ZNF688 ZNF785 ZNF394 ZNF615 ZNF579 ZNF649 ZNF584 ZNF689 ZKSCAN2 ZNF181 ZNF2 ZSCAN20 KLF1 ZNF764 ZNF667 ZNF554	2.00e-04	694	202	19	IPR013087
Domain	C_TYPE_LECTIN_1	FREM1 COLEC12 MRC2 PKD1 CD207 VCAN	2.30e-04	80	202	6	PS00615
Domain	-	COPB2 NWD2 CDC40 BRWD1 WDPCP DENND3 SCAP WDHD1 WDR97 TLE6 WDR12 WDSUB1	2.85e-04	333	202	12	2.130.10.10
Domain	ZINC_FINGER_C2H2_2	ZNF527 DZIP1L ZNF184 ZNF213 ZNF688 ZNF785 ZNF394 ZNF615 ZNF579 ZNF649 ZNF584 ZNF689 ZKSCAN2 ZNF181 ZNF2 ZSCAN20 KLF1 ZNF764 ZNF667 ZNF554	2.93e-04	775	202	20	PS50157
Domain	Lectin_C	FREM1 COLEC12 MRC2 PKD1 CD207 VCAN	3.00e-04	84	202	6	PF00059
Domain	CLECT	FREM1 COLEC12 MRC2 PKD1 CD207 VCAN	3.00e-04	84	202	6	SM00034
Domain	WD40/YVTN_repeat-like_dom	COPB2 NWD2 CDC40 BRWD1 WDPCP DENND3 SCAP WDHD1 WDR97 TLE6 WDR12 WDSUB1	3.01e-04	335	202	12	IPR015943
Domain	ZINC_FINGER_C2H2_1	ZNF527 DZIP1L ZNF184 ZNF213 ZNF688 ZNF785 ZNF394 ZNF615 ZNF579 ZNF649 ZNF584 ZNF689 ZKSCAN2 ZNF181 ZNF2 ZSCAN20 KLF1 ZNF764 ZNF667 ZNF554	3.03e-04	777	202	20	PS00028
Domain	C_TYPE_LECTIN_2	FREM1 COLEC12 MRC2 PKD1 CD207 VCAN	3.20e-04	85	202	6	PS50041
Domain	C-type_lectin-like	FREM1 COLEC12 MRC2 PKD1 CD207 VCAN	3.41e-04	86	202	6	IPR001304
Domain	ChSh	CBX3 CBX1	3.47e-04	3	202	2	SM00300
Domain	Flavin_amine_oxidase	MAOB IL4I1	3.47e-04	3	202	2	IPR001613
Domain	Chromo_shadow_dom	CBX3 CBX1	3.47e-04	3	202	2	IPR008251
Domain	Enolase_N	ENO2 ENO3	3.47e-04	3	202	2	PF03952
Domain	Enolase	ENO2 ENO3	3.47e-04	3	202	2	IPR000941
Domain	Enolase_C	ENO2 ENO3	3.47e-04	3	202	2	IPR020810
Domain	Enolase_N	ENO2 ENO3	3.47e-04	3	202	2	IPR020811
Domain	Enolase_CS	ENO2 ENO3	3.47e-04	3	202	2	IPR020809
Domain	Enolase_C	ENO2 ENO3	3.47e-04	3	202	2	PF00113
Domain	Chromo_shadow	CBX3 CBX1	3.47e-04	3	202	2	PF01393
Domain	Enolase_N	ENO2 ENO3	3.47e-04	3	202	2	SM01193
Domain	Enolase_C	ENO2 ENO3	3.47e-04	3	202	2	SM01192
Domain	ENOLASE	ENO2 ENO3	3.47e-04	3	202	2	PS00164
Domain	SNF2_N	CHD6 CHD9 CHD8 CHD7	3.77e-04	32	202	4	IPR000330
Domain	SNF2_N	CHD6 CHD9 CHD8 CHD7	3.77e-04	32	202	4	PF00176
Domain	SAM	PHC3 PPFIA3 SCML4 SHANK2 WDSUB1 EPHA3	3.86e-04	88	202	6	SM00454
Domain	Znf_C2H2	ZNF527 DZIP1L ZNF184 ZNF213 ZNF688 ZNF785 ZNF394 ZNF615 ZNF579 ZNF649 ZNF584 ZNF689 ZKSCAN2 ZNF181 ZNF2 ZSCAN20 KLF1 ZNF764 ZNF667 ZNF554	4.76e-04	805	202	20	IPR007087
Domain	DNA/RNA_helicase_DEAH_CS	CHD6 CHD8 CHD7 DHX34	5.35e-04	35	202	4	IPR002464
Domain	WD40	COPB2 CDC40 BRWD1 DENND3 SCAP WDHD1 WDR97 TLE6 WDR12 WDSUB1	5.36e-04	259	202	10	PF00400
Domain	SAM_DOMAIN	PHC3 PPFIA3 SCML4 SHANK2 WDSUB1 EPHA3	5.81e-04	95	202	6	PS50105
Domain	SAM	PHC3 PPFIA3 SCML4 SHANK2 WDSUB1 EPHA3	6.49e-04	97	202	6	IPR001660
Domain	-	FREM1 COLEC12 MRC2 PKD1 CD207 VCAN	6.49e-04	97	202	6	3.10.100.10
Domain	CH	SPTBN2 DST FLNA FLNB LMO7	6.87e-04	65	202	5	SM00033
Domain	-	ENO2 ENO3	6.88e-04	4	202	2	3.30.390.10
Domain	LamGL	USH2A PAPPA	6.88e-04	4	202	2	SM00560
Domain	-	ENO2 ENO3	6.88e-04	4	202	2	3.20.20.120
Domain	LamG-like	USH2A PAPPA	6.88e-04	4	202	2	IPR006558
Domain	Enolase_C-like	ENO2 ENO3	6.88e-04	4	202	2	IPR029065
Domain	Enolase_N-like	ENO2 ENO3	6.88e-04	4	202	2	IPR029017
Domain	C-type_lectin-like/link	FREM1 COLEC12 MRC2 PKD1 CD207 VCAN	7.23e-04	99	202	6	IPR016186
Domain	DEAH_ATP_HELICASE	CHD6 CHD8 CHD7 DHX34	7.35e-04	38	202	4	PS00690
Domain	LH2	PKD1 ALOX12B ALOXE3	9.02e-04	18	202	3	SM00308
Domain	CH	SPTBN2 DST FLNA FLNB LMO7	9.64e-04	70	202	5	PF00307
Domain	-	SPTBN2 DST FLNA FLNB LMO7	1.03e-03	71	202	5	1.10.418.10
Domain	-	PHC3 PPFIA3 SCML4 SHANK2 WDSUB1 EPHA3	1.03e-03	106	202	6	1.10.150.50
Domain	CTDL_fold	FREM1 COLEC12 MRC2 PKD1 CD207 VCAN	1.09e-03	107	202	6	IPR016187
Domain	WSC	PKD1 WSCD1	1.14e-03	5	202	2	SM00321
Domain	WSC	PKD1 WSCD1	1.14e-03	5	202	2	PS51212
Domain	Sterol-sensing	NPC1L1 SCAP	1.14e-03	5	202	2	PF12349
Domain	Exostosin	EXT2 RXYLT1	1.14e-03	5	202	2	PF03016
Domain	WSC_carb-bd	PKD1 WSCD1	1.14e-03	5	202	2	IPR002889
Domain	WSC	PKD1 WSCD1	1.14e-03	5	202	2	PF01822
Domain	FATC	SMG1 PRKDC	1.14e-03	5	202	2	PF02260
Domain	Exostosin	EXT2 RXYLT1	1.14e-03	5	202	2	IPR004263
Domain	CH	SPTBN2 DST FLNA FLNB LMO7	1.17e-03	73	202	5	PS50021
Domain	C-type_lectin_CS	COLEC12 MRC2 CD207 VCAN	1.18e-03	43	202	4	IPR018378
Domain	CH-domain	SPTBN2 DST FLNA FLNB LMO7	1.32e-03	75	202	5	IPR001715
Domain	-	PKD1 ALOX12B ALOXE3	1.44e-03	21	202	3	2.60.60.20
Domain	PLAT	PKD1 ALOX12B ALOXE3	1.44e-03	21	202	3	PF01477
Domain	PLAT/LH2_dom	PKD1 ALOX12B ALOXE3	1.44e-03	21	202	3	IPR001024
Domain	PLAT	PKD1 ALOX12B ALOXE3	1.44e-03	21	202	3	PS50095
Domain	LipOase_mml	ALOX12B ALOXE3	1.70e-03	6	202	2	IPR001885
Domain	F-box-assoc_dom	FBXO6 FBXO44	1.70e-03	6	202	2	IPR007397
Domain	LIPOXYGENASE_1	ALOX12B ALOXE3	1.70e-03	6	202	2	PS00711
Domain	LipOase_C	ALOX12B ALOXE3	1.70e-03	6	202	2	IPR013819
Domain	LIPOXYGENASE_2	ALOX12B ALOXE3	1.70e-03	6	202	2	PS00081
Domain	FBA	FBXO6 FBXO44	1.70e-03	6	202	2	PF04300
Domain	LipOase_Fe_BS	ALOX12B ALOXE3	1.70e-03	6	202	2	IPR020833
Domain	LipOase_CS	ALOX12B ALOXE3	1.70e-03	6	202	2	IPR020834
Domain	FAT	SMG1 PRKDC	1.70e-03	6	202	2	PS51189
Domain	FATC	SMG1 PRKDC	1.70e-03	6	202	2	PS51190
Domain	Lipoxygenase	ALOX12B ALOXE3	1.70e-03	6	202	2	PF00305
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	USP34 SMG1 ADGRB3 ADCY9 DST RAB3GAP2 MINAR1 CHD6 PSD3 CHD8 CHD7 PPFIA3 SCAP LMO7	8.51e-11	225	205	14	12168954
Pubmed	Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.	ZNF184 CBX3 ZNF688 ZNF785 EHMT2 CBX1 ZNF615 ZNF649 ZNF689 ZNF181 ZNF764 ZNF554	9.48e-10	181	205	12	37372979
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	USP34 TCAF1 PDE4B DZIP1L COPB2 PPCDC HNRNPK PHC3 PLD1 BRWD1 NRDE2 FLNA TICRR FLNB CPSF6 ITSN1 ANGEL1 CHD7 SCAP WDHD1 PPP6C DDHD1 VCAN TGS1	3.11e-08	1084	205	24	11544199
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	USP34 INPP4A CBX3 PHC3 FASN DST EHMT2 ANAPC1 RAB3GAP2 CHD6 FLNA FLNB CHD8 CHD7 CRK	3.32e-08	418	205	15	34709266
Pubmed	Human POGZ modulates dissociation of HP1alpha from mitotic chromosome arms through Aurora B activation.	CBX3 ZNF688 EHMT2 CBX1 ZNF649 ZNF689 ZNF764 ZNF747	3.43e-08	83	205	8	20562864
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	USP34 GPRASP1 KDM3A STAG1 MYO1E SPTBN2 ADGRB3 MRPS35 ZNF785 STAT3 HNRNPK DST EHMT2 PKD1 CHD6 BRWD1 FLNB ZNF584 ITSN1 CHD9 GRIN2B ZNF181 LMO7 KDM4A PRKDC	1.85e-07	1285	205	25	35914814
Pubmed	The ATP-dependent chromatin remodeling enzymes CHD6, CHD7, and CHD8 exhibit distinct nucleosome binding and remodeling activities.	CHD6 CHD8 CHD7	2.02e-07	3	205	3	28533432
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	KDM3A STAG1 ZNF184 CBX3 PHC3 EHMT2 CBX1 CHD6 ZNF649 BRWD1 CHD9 CHD8 CHD7 FAM169A WDR12 KDM4A	7.61e-07	608	205	16	36089195
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TPP2 GPRASP1 TCAF1 PDE4B SPTBN2 ADGRB3 CBX3 HNRNPK DST ZNF394 EHMT2 ANAPC1 ITSN1 CHD8 CHD7 GRIN2B PPFIA3 RGS6 SHANK2 PPP6C	1.26e-06	963	205	20	28671696
Pubmed	Automethylation of G9a and its implication in wider substrate specificity and HP1 binding.	CBX3 EHMT2 CBX1	2.00e-06	5	205	3	17962312
Pubmed	The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis.	COPB2 HNRNPK FASN FLNA FLNB SCAP WDHD1 TIMP2	2.06e-06	141	205	8	32322062
Pubmed	Localized domains of G9a-mediated histone methylation are required for silencing of neuronal genes.	CBX3 EHMT2 CBX1	3.98e-06	6	205	3	15200951
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	KDM3A PHC3 EHMT2 CBX1 CHD6 CHD8 CHD7 KDM4A	4.58e-06	157	205	8	30186101
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	COPB2 CBX3 ADCY9 STAT3 HNRNPK FASN DST RAB3GAP2 NECTIN2 EIF2AK3 FLNB PSD3 CRK ARHGAP12 PRKDC EPHA3	5.35e-06	708	205	16	39231216
Pubmed	Maintenance of silent chromatin through replication requires SWI/SNF-like chromatin remodeler SMARCAD1.	CBX3 HNRNPK EHMT2 ANAPC1 ZNF649 ZNF689 PRKDC	6.04e-06	116	205	7	21549307
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	TTC21A SPTBN2 COPB2 HNRNPK TMEM260 DST PKD1 CHD6 TICRR FLNB ITSN1 MAGEE2 PCARE PPFIA3 PRKDC RPE65	8.67e-06	736	205	16	29676528
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	TPP2 SMG1 TCAF1 STAG1 SPTBN2 CBX3 HNRNPK DST RAB3GAP2 FLNA FLNB VCAN ENO2	9.27e-06	498	205	13	36634849
Pubmed	MYH9-dependent polarization of ATG9B promotes colorectal cancer metastasis by accelerating focal adhesion assembly.	FASN FLNA FLNB	1.11e-05	8	205	3	34131310
Pubmed	Proteomic analysis of the SIRT6 interactome: novel links to genome maintenance and cellular stress signaling.	HNRNPK ANAPC1 FLNA FLNB WDHD1 PRKDC	1.32e-05	87	205	6	24169447
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SMG1 STAG1 DZIP1L SPTBN2 SKIDA1 CBX3 MRPS35 PHEX FASN DST CHD6 FLNA FLNB ITSN1 RBM42 SCML4 SHANK2 LMO7 TNN ARHGAP12 FAM169A PADI6 PRKDC	1.57e-05	1442	205	23	35575683
Pubmed	Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q.	SMG1 ZNF688 ZNF785 PKD1 SCNN1B ZNF747	1.82e-05	92	205	6	10493829
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	STAG1 INPP4A ADGRB3 HNRNPK NWD2 C3 CHD6 PSD3 CHD8 ARHGAP12 ENO2 ENO3	2.83e-05	475	205	12	31040226
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	FCGR2B EHMT2 PKD1 FLNA FLNB PPFIA3 RGS7 CRK FCGR2C SHANK2	2.85e-05	329	205	10	17474147
Pubmed	Isolation and characterization of proteins associated with histone H3 tails in vivo.	CBX3 HNRNPK EHMT2 CBX1	2.85e-05	30	205	4	17403666
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	COPB2 HNRNPK FASN ANAPC1 FLNA FLNB CHD8 WDHD1 LMO7 PRKDC	3.07e-05	332	205	10	32786267
Pubmed	Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein-1γ in reprogramming to pluripotency.	CBX3 EHMT2 CBX1	3.22e-05	11	205	3	23748610
Pubmed	Dynamic Histone H1 Isotype 4 Methylation and Demethylation by Histone Lysine Methyltransferase G9a/KMT1C and the Jumonji Domain-containing JMJD2/KDM4 Proteins.	CBX3 EHMT2 KDM4A	3.22e-05	11	205	3	19144645
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	USP34 MYO1E ADCY9 TYK2 JAG2 FASN DST PKD1 ZER1 ZNF579 MPP3 FLNA CHD8 C2CD2 PWWP2B SCAP SHANK2 PRKDC DHX34	3.30e-05	1105	205	19	35748872
Pubmed	Involvement of tenascin-C and PG-M/versican in flexor tenosynovial pathology of idiopathic carpal tunnel syndrome.	TNC VCAN	3.46e-05	2	205	2	16493581
Pubmed	The hypoxia-inducible epigenetic regulators Jmjd1a and G9a provide a mechanistic link between angiogenesis and tumor growth.	KDM3A EHMT2	3.46e-05	2	205	2	25071150
Pubmed	Disruption of the Flnb gene in mice phenocopies the human disease spondylocarpotarsal synostosis syndrome.	FLNA FLNB	3.46e-05	2	205	2	17635842
Pubmed	G9a and Jhdm2a regulate embryonic stem cell fusion-induced reprogramming of adult neural stem cells.	KDM3A EHMT2	3.46e-05	2	205	2	18535151
Pubmed	CHD8 interacts with CHD7, a protein which is mutated in CHARGE syndrome.	CHD8 CHD7	3.46e-05	2	205	2	20453063
Pubmed	Lipoxygenase-3 (ALOXE3) and 12(R)-lipoxygenase (ALOX12B) are mutated in non-bullous congenital ichthyosiform erythroderma (NCIE) linked to chromosome 17p13.1.	ALOX12B ALOXE3	3.46e-05	2	205	2	11773004
Pubmed	Filamin depletion blocks endoplasmic spreading and destabilizes force-bearing adhesions.	FLNA FLNB	3.46e-05	2	205	2	21325628
Pubmed	Lack of association between TYK2 and STAT3 genes and Crohn's disease in the Malaysian population.	STAT3 TYK2	3.46e-05	2	205	2	23408403
Pubmed	Identification and characterization of posttranslational modification-specific binding proteins in vivo by mammalian tethered catalysis.	EHMT2 CBX1	3.46e-05	2	205	2	19706462
Pubmed	Improved efficacy of gene therapy approaches for Pompe disease using a new, immune-deficient GSD-II mouse model.	PRKDC GAA	3.46e-05	2	205	2	15356673
Pubmed	Tyk2 tyrosine kinase expression is required for the maintenance of mitochondrial respiration in primary pro-B lymphocytes.	STAT3 TYK2	3.46e-05	2	205	2	16982690
Pubmed	Mammalian oocytes store proteins for the early embryo on cytoplasmic lattices.	TLE6 PADI6	3.46e-05	2	205	2	37922900
Pubmed	Interaction between RGS7 and polycystin.	PKD1 RGS7	3.46e-05	2	205	2	10339594
Pubmed	TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells.	STAT3 TIMP2	3.46e-05	2	205	2	33023532
Pubmed	Structural and functional aspects of filamins.	FLNA FLNB	3.46e-05	2	205	2	11336782
Pubmed	The importance of the lipoxygenase-hepoxilin pathway in the mammalian epidermal barrier.	ALOX12B ALOXE3	3.46e-05	2	205	2	24021977
Pubmed	The variants at FLNA and FLNB contribute to the susceptibility of hypertension and stroke with differentially expressed mRNA.	FLNA FLNB	3.46e-05	2	205	2	33649519
Pubmed	Strong evidence of a combination polymorphism of the tyrosine kinase 2 gene and the signal transducer and activator of transcription 3 gene as a DNA-based biomarker for susceptibility to Crohn's disease in the Japanese population.	STAT3 TYK2	3.46e-05	2	205	2	19653082
Pubmed	12R-lipoxygenase deficiency disrupts epidermal barrier function.	ALOX12B ALOXE3	3.46e-05	2	205	2	17403930
Pubmed	Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer.	TNC VCAN	3.46e-05	2	205	2	15073129
Pubmed	Two novel mutations in PADI6 and TLE6 genes cause female infertility due to arrest in embryonic development.	TLE6 PADI6	3.46e-05	2	205	2	34036456
Pubmed	Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis.	PKD1 PAPPA	3.46e-05	2	205	2	31990681
Pubmed	Human IgG Fc receptor (hFcRII; CD32) exists as multiple isoforms in macrophages, lymphocytes and IgG-transporting placental epithelium.	FCGR2B FCGR2C	3.46e-05	2	205	2	2531080
Pubmed	Pregnancy-associated plasma protein A (PAPP-A) specifically inhibits the third component of human complement (C3).	C3 PAPPA	3.46e-05	2	205	2	6203109
Pubmed	TCAF1 promotes TRPV2-mediated Ca2+ release in response to cytosolic DNA to protect stressed replication forks.	TCAF1 TRPV2	3.46e-05	2	205	2	38816425
Pubmed	Direct and biologically significant interactions of human herpesvirus 8 interferon regulatory factor 1 with STAT3 and Janus kinase TYK2.	STAT3 TYK2	3.46e-05	2	205	2	37983265
Pubmed	Regulation of an inducible promoter by an HP1beta-HP1gamma switch.	CBX3 CBX1	3.46e-05	2	205	2	18239689
Pubmed	Functional domain analysis of human HP1 isoforms in Drosophila.	CBX3 CBX1	3.46e-05	2	205	2	17575412
Pubmed	Hyper-IgE syndrome.	STAT3 TYK2	3.46e-05	2	205	2	19717292
Pubmed	Tenascin-C and tenascin-W in whisker follicle stem cell niches: possible roles in regulating stem cell proliferation and migration.	TNC TNN	3.46e-05	2	205	2	24101721
Pubmed	[Fatty acid synthase interacts with signal transducer and activator of transcription 3 to promote migration and invasion in liver cancer cells].	STAT3 FASN	3.46e-05	2	205	2	31594092
Pubmed	TYK2-induced phosphorylation of Y640 suppresses STAT3 transcriptional activity.	STAT3 TYK2	3.46e-05	2	205	2	29162862
Pubmed	Mutations associated with a congenital form of ichthyosis (NCIE) inactivate the epidermal lipoxygenases 12R-LOX and eLOX3.	ALOX12B ALOXE3	3.46e-05	2	205	2	15629692
Pubmed	A sequence motif found in a Drosophila heterochromatin protein is conserved in animals and plants.	CBX3 CBX1	3.46e-05	2	205	2	1708124
Pubmed	hnRNP K interacts with RNA binding motif protein 42 and functions in the maintenance of cellular ATP level during stress conditions.	HNRNPK RBM42	3.46e-05	2	205	2	19170760
Pubmed	Expression of functional CD32 molecules on human NK cells is determined by an allelic polymorphism of the FcgammaRIIC gene.	FCGR2B FCGR2C	3.46e-05	2	205	2	9516136
Pubmed	Molecular analysis of 250 patients with autosomal recessive congenital ichthyosis: evidence for mutation hotspots in ALOXE3 and allelic heterogeneity in ALOX12B.	ALOX12B ALOXE3	3.46e-05	2	205	2	19131948
Pubmed	Colorectal carcinomas with CpG island methylator phenotype 1 frequently contain mutations in chromatin regulators.	CHD8 CHD7	3.46e-05	2	205	2	24211491
Pubmed	The ER Stress Sensor PERK Coordinates ER-Plasma Membrane Contact Site Formation through Interaction with Filamin-A and F-Actin Remodeling.	EIF2AK3 FLNA	3.46e-05	2	205	2	28238652
Pubmed	LIFR-α-dependent adipocyte signaling in obesity limits adipose expansion contributing to fatty liver disease.	STAT3 LIFR	3.46e-05	2	205	2	33748712
Pubmed	Activation of DNA-PK by ionizing radiation is mediated by protein phosphatase 6.	PPP6C PRKDC	3.46e-05	2	205	2	19198648
Pubmed	The adhesion modulating properties of tenascin-W.	TNC TNN	3.46e-05	2	205	2	22211116
Pubmed	Identification of Jmjd1a as a STAT3 downstream gene in mES cells.	KDM3A STAT3	3.46e-05	2	205	2	16988490
Pubmed	Meta-Analysis of Mutations in ALOX12B or ALOXE3 Identified in a Large Cohort of 224 Patients.	ALOX12B ALOXE3	3.46e-05	2	205	2	33435499
Pubmed	Lipoxygenases mediate the effect of essential fatty acid in skin barrier formation: a proposed role in releasing omega-hydroxyceramide for construction of the corneocyte lipid envelope.	ALOX12B ALOXE3	3.46e-05	2	205	2	21558561
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	TPP2 USP34 SPTBN2 COPB2 CBX3 FASN DST ANAPC1 FLNA FLNB CHD8 CHD7 WDR12 PRKDC	3.72e-05	653	205	14	22586326
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	USP34 CBX3 ADCY9 TYK2 EHMT2 ANAPC1 GRAP2 CBX1 PLD1 ZNF579 BRWD1 ANGEL1 CHD9 CHD8 ZKSCAN2 PPFIA3 TCHH PWWP2B DHX34	3.77e-05	1116	205	19	31753913
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	TPP2 MYO1E INPP4A TTC21A SPTBN2 COPB2 HNRNPK FASN NWD2 DST REEP5 FLNA FLNB TNC ITSN1 PSD3 GRIN2B PPFIA3 SHANK2 LMO7 VCAN ENO2	4.21e-05	1431	205	22	37142655
Pubmed	TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation.	EHMT2 CHD6 CHD9 CHD8 CHD7 EPHA3	4.77e-05	109	205	6	33554859
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	USP34 MRPS35 PHC3 EHMT2 ANAPC1 CHD6 CHD9 CHD8 CHD7	4.93e-05	282	205	9	23667531
Pubmed	Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome.	CBX3 CBX1 FLNA FLNB CPSF6 CHD8 VCAN PRKDC	5.07e-05	219	205	8	31353912
Pubmed	Protein interaction profiling of the p97 adaptor UBXD1 points to a role for the complex in modulating ERGIC-53 trafficking.	COPB2 DST RAB3GAP2 PRKDC	5.32e-05	35	205	4	22337587
Pubmed	Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation.	HNRNPK FAP DST MRC2 NECTIN2 FLNA FLNB TNC LMO7	5.35e-05	285	205	9	21423176
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	HNRNPK DST EHMT2 ZNF579 TRMT61B MAP4K2 FLNA FLNB LMO7 PRKDC	6.06e-05	360	205	10	33111431
Pubmed	Spatiotemporal single-cell regulatory atlas reveals neural crest lineage diversification and cellular function during tooth morphogenesis.	PHEX BMP3 TAC1 EPHA3	6.65e-05	37	205	4	35974052
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	USP34 SMG1 COPB2 MRPS35 PPP1R15A HNRNPK FASN CDC40 ANAPC1 EIF3M FLNA FLNB CPSF6 RBM42 WDHD1 PPP6C FAM169A	6.98e-05	971	205	17	33306668
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP34 SMG1 KDM3A ADGRB3 ADCY9 DST MRC2 CHD8 LMO7 DDHD1 KDM4A DHX34	7.93e-05	529	205	12	14621295
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	SPTBN2 COPB2 CBX3 HNRNPK NWD2 DST CDC40 MAMDC2 CBX1 CHD6 SLC25A24 NRDE2 CPSF6 RBM42 CHD9 CHD7 VCAN PRKDC	8.14e-05	1082	205	18	38697112
Pubmed	Quantitative trait loci affecting the 3D skull shape and size in mouse and prioritization of candidate genes in-silico.	FREM1 FCGR2B CHD7 EPHA3	8.20e-05	39	205	4	25859222
Pubmed	A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells.	FASN FLNA CPSF6 CHD8 CRK FAM169A	8.53e-05	121	205	6	22412018
Pubmed	Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1.	CBX3 CBX1 PRKDC	8.71e-05	15	205	3	19661379
Pubmed	A novel view of the transcriptome revealed from gene trapping in mouse embryonic stem cells.	INPP4A EIF2AK3 ITSN1 C2orf80	9.07e-05	40	205	4	17540781
Pubmed	Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation.	FASN MRC2 TNC VCAN	9.07e-05	40	205	4	16210410
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	MYO1E COPB2 CBX3 MRPS35 HNRNPK FASN C3 EIF3M FLNA FLNB CPSF6 LMO7 ZNF667 PRKDC	9.20e-05	711	205	14	33022573
Pubmed	Quantitative nanoproteomics for protein complexes (QNanoPX) related to estrogen transcriptional action.	HNRNPK FLNA FLNB PRKDC	1.00e-04	41	205	4	19805454
Pubmed	Borrelia burgdorferi enolase is a surface-exposed plasminogen binding protein.	ENO2 ENO3	1.03e-04	3	205	2	22087329
Pubmed	FAP is critical for ovarian cancer cell survival by sustaining NF-κB activation through recruitment of PRKDC in lipid rafts.	FAP PRKDC	1.03e-04	3	205	2	36494579
Pubmed	Opposing FlnA and FlnB interactions regulate RhoA activation in guiding dynamic actin stress fiber formation and cell spreading.	FLNA FLNB	1.03e-04	3	205	2	28175289
Pubmed	Fcγ receptor IIB (FcγRIIB) maintains humoral tolerance in the human immune system in vivo.	FCGR2B PRKDC	1.03e-04	3	205	2	22065769
Pubmed	The role of lipoxygenases in epidermis.	ALOX12B ALOXE3	1.03e-04	3	205	2	23954555
Pubmed	The histone H3K9 demethylase KDM3A promotes anoikis by transcriptionally activating pro-apoptotic genes BNIP3 and BNIP3L.	KDM3A BNIP3L	1.03e-04	3	205	2	27472901
Pubmed	STAT3 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin.	STAT3 MYOCD	1.03e-04	3	205	2	26100622
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	ZNF527 PPP1R15A NECTIN2 ZNF615 ZNF579 ZNF649 IL4I1 NLRP13 SERTAD1 ZNF584 RBM42 PPFIA3 ZNF181 LIPE ZNF667 DHX34	1.01e-04	1192	205	16	chr19q13
Cytoband	8q11	PRKDC TGS1	2.94e-04	6	205	2	8q11
Cytoband	2q11.2	INPP4A VWA3B FER1L5 ZNF2	3.13e-04	72	205	4	2q11.2
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF527 ZNF184 ZNF213 ZNF688 ZNF785 ZNF394 ZNF615 ZNF579 ZNF649 ZNF584 ZNF689 ZKSCAN2 ZNF181 ZNF2 ZSCAN20 KLF1 ZNF764 ZNF667 ZNF747 ZNF554	7.69e-07	718	141	20	28
GeneFamily	WD repeat domain containing	COPB2 CDC40 BRWD1 DENND3 SCAP WDHD1 WDR97 TLE6 WDR12 WDSUB1	4.02e-05	262	141	10	362
GeneFamily	Sterile alpha motif domain containing	PHC3 PPFIA3 SCML4 SHANK2 WDSUB1 EPHA3	6.48e-05	88	141	6	760
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	FREM1 COLEC12 PKD1 VCAN	2.87e-04	41	141	4	1298
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	CHD6 ZKSCAN2 CHD7 ZSCAN20	7.72e-04	53	141	4	532
GeneFamily	Arachidonate lipoxygenases	ALOX12B ALOXE3	8.87e-04	6	141	2	407
GeneFamily	Fibronectin type III domain containing	USH2A IL27RA TNC LIFR TNN EPHA3	1.60e-03	160	141	6	555
GeneFamily	Chromobox family	CBX3 CBX1	1.64e-03	8	141	2	976
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	INPP4A ITSN1 C2CD2	2.75e-03	36	141	3	823
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	MAOB FREM1 PHEX COLEC12 DST MRC2 ADAMTS3 TNC ITSN1 PSD3 LIFR VCAN	1.58e-10	200	204	12	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAOB ADGRB3 FREM1 PHEX COLEC12 FAP DST MRC2 TNC LIFR VCAN	1.70e-09	194	204	11	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	LPS_IL1RA_TNF\|World / Treatment groups by lineage, cell group, cell type	ADGRB3 PHEX COLEC12 MRC2 MAMDC2 MPP3 TNC CHD9 FAM13A LMO7 VCAN	1.99e-09	197	204	11	0a6550dce156fc81f15b1e7830d331ca50d87d06
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAOB ADGRB3 FREM1 PHEX COLEC12 MRC2 ADAMTS3 TNC VCAN PAPPA	2.02e-08	191	204	10	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAOB ADGRB3 FREM1 PHEX COLEC12 MRC2 MAMDC2 ADAMTS3 TNC PSD3	2.23e-08	193	204	10	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	ADGRB3 PHEX COLEC12 BMP3 MRC2 MAMDC2 TNC LIFR LMO7 PAPPA	2.85e-08	198	204	10	6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FREM1 PHEX COLEC12 DST MRC2 ADAMTS3 TNC PSD3 LIFR VCAN	2.99e-08	199	204	10	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MAOB FREM1 PHEX COLEC12 DST MRC2 TNC ITSN1 NMNAT3 VCAN	2.99e-08	199	204	10	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FREM1 PHEX COLEC12 DST MRC2 ADAMTS3 TNC PSD3 LIFR VCAN	3.13e-08	200	204	10	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FREM1 PHEX COLEC12 DST MRC2 TNC ITSN1 PSD3 NMNAT3 LIFR	3.13e-08	200	204	10	b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FREM1 PHEX COLEC12 DST MRC2 TNC ITSN1 PSD3 NMNAT3 LIFR	3.13e-08	200	204	10	50ca6550998e461ef26dd670351060bd940765a8
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MAOB FREM1 PHEX COLEC12 DST MRC2 TNC PSD3 NMNAT3 VCAN	3.13e-08	200	204	10	44a68bacdb3d5bf563bd35952176995850933a81
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MAOB FREM1 PHEX COLEC12 DST MRC2 TNC PSD3 NMNAT3 VCAN	3.13e-08	200	204	10	dc61016c61729f69649cfb21f6264e685ce83dea
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	FREM1 PHEX COLEC12 FAP DST MRC2 ADAMTS3 TNC PSD3 VCAN	3.13e-08	200	204	10	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BMP3 C3 NLRP13 MPP3 DENND3 NTN4 SHANK2 LMO7	1.58e-07	130	204	8	6434d9106ccb38786dad36fab80163dfc07b6eb7
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1E SPTBN2 ADCY9 FREM1 SCNN1B ADAMTS3 NTN4 SHANK2 PAPPA	1.63e-07	181	204	9	aa233b652921848af2257cc3687a7a09c3acfb67
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAOB ADGRB3 ADCY9 FREM1 PHEX COLEC12 ADAMTS3 TNC PAPPA	2.35e-07	189	204	9	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FREM1 PHEX COLEC12 NWD2 MAMDC2 TNC PAPPA MYOCD EPHA3	2.57e-07	191	204	9	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	COVID-19-Heart-Fib_2\|Heart / Disease (COVID-19 only), tissue and cell type	ADGRB3 FAP MRC2 C3 TNC TIMP2 VCAN PAPPA EPHA3	2.93e-07	194	204	9	d91c9f2ec47319051fc398320693fddbe8bbd4d6
ToppCell	COVID-19-Heart-Fib_1\|Heart / Disease (COVID-19 only), tissue and cell type	ADGRB3 FREM1 COLEC12 MRC2 MAMDC2 C3 TIMP2 VCAN EPHA3	3.06e-07	195	204	9	f423baa36ac7cdc383c033e35a7d17e6bf913323
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	STAG1 ADGRB3 BNIP3L MRC2 MAMDC2 C3 CHD9 VCAN PAPPA	3.06e-07	195	204	9	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PHEX COLEC12 FASN MRC2 C3 TNC ITSN1 VCAN PAPPA	3.63e-07	199	204	9	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	wk_15-18-Mesenchymal-Fibroblast-Alveolar_fibro\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	TCAF1 FREM1 COLEC12 BNIP3L DST SMPDL3A MRC2 LIFR VCAN	3.63e-07	199	204	9	6bce8e65859a35cfea1c210f9c9765952d492ed2
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MAOB ADGRB3 FREM1 PHEX FAP MAMDC2 DPYS TNC	1.95e-06	181	204	8	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COLEC12 MRC2 MAMDC2 TAC1 TNC VCAN PAPPA EPHA3	2.03e-06	182	204	8	3dfa9187e9d2bab1d199079d29209c4648220ada
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRSS22 BMP3 C3 MPP3 NTN4 SHANK2 FAM13A LMO7	2.29e-06	185	204	8	fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRSS22 NPC1L1 MPP3 LIPE SHANK2 INSL6 LMO7	2.73e-06	133	204	7	5bf5e654653e2c340891f51e3f2a30441b7b6b2b
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MAOB PHEX COLEC12 MAMDC2 TNC LIFR VCAN EPHA3	2.79e-06	190	204	8	7986586b7c82e91c71102cc8c4d7a689ae63ab4d
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	STAT3 COLEC12 C3 ADAMTS3 LIFR VCAN PAPPA EPHA3	2.79e-06	190	204	8	0fea33f2dc1efa23aaa2da1c318482a52a313ff1
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADGRB3 STAT3 COLEC12 MRC2 TNC LIFR VCAN PAPPA	2.90e-06	191	204	8	08720998aa55131d7377c4c67c4c935865bd7d79
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAOB ADGRB3 FREM1 PHEX COLEC12 MRC2 ADAMTS3 TNC	3.02e-06	192	204	8	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	PND14-Mesenchymal-Mesenchymal_structural\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FREM1 PHEX COLEC12 BMP3 MRC2 MAMDC2 TIMP2 VCAN	3.02e-06	192	204	8	25492568f9cbe097b7bb1db50d8b817c80ea87d7
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FREM1 PHEX COLEC12 BMP3 MRC2 MAMDC2 TIMP2 VCAN	3.02e-06	192	204	8	de9c1536d5aee86f9c62acbc54ca8fa581c00f17
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ADGRB3 PPP1R15A FREM1 STAT3 COLEC12 NECTIN2 SERTAD1 VCAN	3.13e-06	193	204	8	cf3cbf79ccd34ddcf06ec6194a18a7afd7f91f39
ToppCell	LV-01._Fibroblast_I\|LV / Chamber and Cluster_Paper	ADGRB3 BNIP3L MRC2 MAMDC2 C3 CHD9 VCAN PAPPA	3.13e-06	193	204	8	dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	MAOB ADGRB3 FREM1 PHEX FAP DST MRC2 TNC	3.13e-06	193	204	8	acad568621ed677031797b8c2e34dafea798d681
ToppCell	RV-02._Fibroblast_II\|RV / Chamber and Cluster_Paper	ADGRB3 BNIP3L MRC2 MAMDC2 C3 CHD9 VCAN PAPPA	3.26e-06	194	204	8	11c79a8c56ece42713b04b321982e41e239f07a5
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADGRB3 FREM1 PHEX COLEC12 MRC2 ADAMTS3 TNC PAPPA	3.26e-06	194	204	8	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	LV-02._Fibroblast_II\|LV / Chamber and Cluster_Paper	ADGRB3 BNIP3L MRC2 MAMDC2 C3 CHD9 VCAN PAPPA	3.26e-06	194	204	8	014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAOB ADGRB3 FREM1 PHEX COLEC12 MRC2 ADAMTS3 TNC	3.26e-06	194	204	8	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COLEC12 FAP CILP2 MRC2 C3 TNC TIMP2 VCAN	3.38e-06	195	204	8	47762d9e442fb1f6f0033e3e10f4c6e498d2c081
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MAOB PHEX COLEC12 BNIP3L DST SMPDL3A MAMDC2 LIFR	3.51e-06	196	204	8	6730743cf088c419ccc2d28765769fc09d3ba6a7
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MAOB PHEX COLEC12 BNIP3L DST SMPDL3A MAMDC2 LIFR	3.51e-06	196	204	8	21dab89f3699037138a9c7a0e4dc98739a9fad9c
ToppCell	droplet-Limb_Muscle-nan-18m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COLEC12 CILP2 MRC2 C3 TAC1 TNC TIMP2 GAA	3.51e-06	196	204	8	fcb275746bf51269ed8ba4cf93edb054a45f1ccd
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	BMP3 FASN C3 MPP3 NTN4 LIPE FAM13A LMO7	3.65e-06	197	204	8	1485933986921ff45669d9b7501c8d17050b3e97
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	BMP3 FASN C3 MPP3 NTN4 LIPE FAM13A LMO7	3.65e-06	197	204	8	1a1bee8da6e04b65935c40373eaee4d6c046d9a1
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MAOB PHEX COLEC12 MRC2 TNC PSD3 NMNAT3 VCAN	3.79e-06	198	204	8	0a4b19c3d5e65ecd24fc2ce80ac5276c813282c7
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	MAOB ADGRB3 FAP DST MRC2 MAMDC2 VCAN PAPPA	3.79e-06	198	204	8	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADGRB3 FREM1 COLEC12 DST MRC2 TNC LIFR VCAN	3.79e-06	198	204	8	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	356C-Fibroblasts-Fibroblast-J_(Lipofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	PDE4B PPP1R15A CILP2 C3 IL4I1 IL27RA GALNT14 DPYS	3.93e-06	199	204	8	f4fdf94c561dca35bb17766d908c5030655f43eb
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PHEX COLEC12 MRC2 C3 TNC ITSN1 NMNAT3 VCAN	3.93e-06	199	204	8	06a7d874ff7c4616577f6e59d3118717a8c47c00
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	STAT3 PHEX COLEC12 MRC2 C3 TNC NMNAT3 VCAN	3.93e-06	199	204	8	fde2b65afde69f402f1b7b056eaa266e9fd5b227
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	FREM1 PHEX COLEC12 MRC2 TNC PSD3 NMNAT3 VCAN	3.93e-06	199	204	8	c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FREM1 PHEX COLEC12 DST MRC2 TNC LIFR VCAN	3.93e-06	199	204	8	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_only-Mesenchymal_fibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	MAOB PHEX COLEC12 MRC2 C3 TNC NMNAT3 VCAN	3.93e-06	199	204	8	211c3a08f2d484ab7a3368006767289088f0d957
ToppCell	distal-1-Hematologic-EREG+_Dendritic\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PDE4B TMIGD3 FCGR2B SMPDL3A MAMDC2 DENND3 TCHH VCAN	3.93e-06	199	204	8	15249f2f48b1e99d9d062835fd4c705a159e4abb
ToppCell	ILEUM-inflamed-(8)_Fibroblasts\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	DST MAMDC2 FLNB TNC PSD3 TIMP2 VCAN PAPPA	3.93e-06	199	204	8	3a3e2bb21cd0293622b1a975263e918d9ba24265
ToppCell	18-Distal-Mesenchymal-Mesenchyme_RSPO2+\|Distal / Age, Tissue, Lineage and Cell class	PHEX COLEC12 FAP BNIP3L DST SMPDL3A LIFR VCAN	3.93e-06	199	204	8	95403988caef322314f4ed15415ad1a9a987adc1
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PHEX COLEC12 MRC2 C3 TNC ITSN1 NMNAT3 VCAN	3.93e-06	199	204	8	ba586690f88fd051f449753bfe7603a2cb431782
ToppCell	Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	COLEC12 FAP DST MRC2 TNC PSD3 TIMP2 VCAN	3.93e-06	199	204	8	40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PHEX COLEC12 MRC2 C3 TNC ITSN1 NMNAT3 VCAN	3.93e-06	199	204	8	38ed3bc7daa993d9edcf3e7834597ebb06dd24f8
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts\|LPS_only / Treatment groups by lineage, cell group, cell type	MAOB PHEX COLEC12 MRC2 C3 TNC NMNAT3 VCAN	3.93e-06	199	204	8	1a0add79f4e34078b3475eb11c85a4234bda197c
ToppCell	ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	DST SMPDL3A MAMDC2 FLNB PSD3 LIFR VCAN PAPPA	3.93e-06	199	204	8	615f20bf136dfef53b072667cf0e4df6a1017e05
ToppCell	356C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	PDE4B PPP1R15A CILP2 C3 IL4I1 IL27RA GALNT14 DPYS	3.93e-06	199	204	8	c0fe99ed906d0eb99cccdab9a1fa32c17b3542e7
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	BMP3 FASN C3 MPP3 NTN4 LIPE FAM13A LMO7	4.08e-06	200	204	8	e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae
ToppCell	Control_saline-Mesenchymal_fibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	FREM1 PHEX COLEC12 MRC2 TNC PSD3 NMNAT3 VCAN	4.08e-06	200	204	8	64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell	wk_20-22-Mesenchymal-Fibroblast-Alveolar_fibro\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	PHEX COLEC12 BNIP3L DST SMPDL3A MRC2 LIFR VCAN	4.08e-06	200	204	8	0ed49c2177b58269ff7653db6be7d68633a5d34a
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts\|Control_saline / Treatment groups by lineage, cell group, cell type	FREM1 PHEX COLEC12 MRC2 TNC PSD3 NMNAT3 VCAN	4.08e-06	200	204	8	a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sncg\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FREM1 BMP3 CILP2 GALNT14 TNC SCML4 PWWP2B	4.21e-06	142	204	7	ed91d2ef4c346f7e1a5402846e2a34cee19c24d1
ToppCell	E18.5-samps-Mesenchymal-Myofibroblast-MyoFB-1\|E18.5-samps / Age Group, Lineage, Cell class and subclass	SPTBN2 CILP2 VWA3B TMPRSS11E ZSCAN20 KLF1 TNN	4.84e-06	145	204	7	ac41c6c02b7d78162b86222983688f54d04ac47d
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	IL27RA TICRR CHD8 PPFIA3 RGS7 FAM169A KDM4A	8.85e-06	159	204	7	f34f2729a3872fbb2939e76ad35d7e25f71b8f57
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal-Unfolded_protein_responsible_cell\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	IL27RA TICRR CHD8 PPFIA3 RGS7 FAM169A KDM4A	8.85e-06	159	204	7	929ed98f6c2ad14e8d5af5c6f11a5a3d4b388cf7
ToppCell	356C-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SMG1 ADGRB3 DST MAMDC2 TNC MAGEE2 PCARE	9.22e-06	160	204	7	0293b244c063a62819690bf22bbc2681f8d15252
ToppCell	356C-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	SMG1 ADGRB3 DST MAMDC2 TNC MAGEE2 PCARE	9.22e-06	160	204	7	3eaae86fa08f7651021316f8e5811bf48055591e
ToppCell	356C-Myeloid-Mast_cell-\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	GPRASP1 MAOB CDK15 FREM1 GRAP2 WSCD1 KLF1	1.08e-05	164	204	7	f7288ec4daf494dae770ea6c58bead27660ccae1
ToppCell	356C-Myeloid-Mast_cell\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	GPRASP1 MAOB CDK15 FREM1 GRAP2 WSCD1 KLF1	1.08e-05	164	204	7	b3192c443f4848e6a8afdb89c155f9ec42a154b0
ToppCell	10x5'-Lung-Lymphocytic_T_CD8-Trm_gut_CD8\|Lung / Manually curated celltypes from each tissue	GPRASP1 FREM1 GRAP2 CHST12 TICRR CAMK4 SCML4	1.42e-05	171	204	7	c8ccb7795ce8321739e3bc07db2ffc183d04e660
ToppCell	FLU-Healthy-3\|Healthy / Virus stimulation, Condition and Cluster	FBXO6 NECTIN2 ZNF579 IL4I1 NMNAT3 LMO7 ZNF554	1.53e-05	173	204	7	26e89ac86922f1cd0100cf4d1cce37e74dd31c88
ToppCell	FLU-Healthy-3\|FLU / Virus stimulation, Condition and Cluster	FBXO6 NECTIN2 ZNF579 IL4I1 NMNAT3 LMO7 ZNF554	1.53e-05	173	204	7	32b8e5b400885dbeba57a7cb2c18d882664dc285
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRSS22 BMP3 C3 MPP3 NTN4 SHANK2 LMO7	1.59e-05	174	204	7	d0e3d15731de6c19c232e3aa492c39d8151cf4ed
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4\|TCGA-Lung / Sample_Type by Project: Shred V9	TMIGD3 FAP CILP2 FCGR2B FCGR2C TIMP2 VCAN	1.71e-05	176	204	7	0923b01137d6f9956ca815b41102c81e82624065
ToppCell	LPS-IL1RA+antiTNF\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FREM1 MAMDC2 MPP3 LIFR SHANK2 FAM13A LMO7	1.78e-05	177	204	7	b7fee75de7e96924af488a5baa2334711889ae7c
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NWD2 MRC2 TAC1 TNC VCAN PAPPA EPHA3	1.78e-05	177	204	7	bd602db857f37869ef76d14c05ef522c509f08ee
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRSS22 SCNN1B MPP3 DENND3 NTN4 SHANK2 LMO7	1.78e-05	177	204	7	9af14a056eb6d88c6f11b09f6d4c0d3448d647d5
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS22 BMP3 CILP2 C3 LRIT2 TNC ENO2	1.84e-05	178	204	7	445fb243d738a34794d66f34b92dde1f3ea6738e
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TTC21A DZIP1L CFAP92 VWA3B DNAH1 ADGB WDR97	1.84e-05	178	204	7	3b12db04006db6e94fc45649a4b3a63b92f21a61
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DZIP1L CBX3 ZNF213 FAP FLNB C2CD2 TIMP2	1.91e-05	179	204	7	ce3ca7f3a5864e62307aa744a3173f350a90df28
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SPTBN2 FREM1 SCNN1B ADAMTS3 PSD3 SCML4 PAPPA	1.91e-05	179	204	7	d3438fed0d85d5ed5afa8ff820c45143d77b6c0d
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FREM1 PHEX COLEC12 NWD2 MAMDC2 ADAMTS3 TNC	1.98e-05	180	204	7	9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FREM1 PHEX COLEC12 NWD2 MAMDC2 ADAMTS3 TNC	2.05e-05	181	204	7	9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRSS22 SCNN1B MPP3 DENND3 NTN4 SHANK2 LMO7	2.05e-05	181	204	7	b45b11428d13950369347e051d4d517efb2bd4fd
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS22 SCNN1B ADAMTS3 GRIN2B FAM169A TLE6 ENO2	2.05e-05	181	204	7	7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRSS22 BMP3 C3 MPP3 NTN4 FAM13A LMO7	2.12e-05	182	204	7	17ed11a7ea366dd3106400511d5e628d3f1a9c3e
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SPTBN2 FREM1 SCNN1B ADAMTS3 GRIN2B SCML4 PAPPA	2.20e-05	183	204	7	b5ede5a0048c585b73c00e88aeddbcaf669347b1
ToppCell	LPS_only-Epithelial_alveolar-AT_2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRSS22 BMP3 C3 MPP3 NTN4 SHANK2 LMO7	2.20e-05	183	204	7	e972432dd4d1bd31bb0982f4df3061e5e152658f
ToppCell	Control-Epithelial_alveolar-AT_2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRSS22 BMP3 C3 MPP3 NTN4 SHANK2 LMO7	2.28e-05	184	204	7	51e129b3fcc2df083eda05a3afe3717218b1e52b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1E DST C3 TNC CAMK4 PSD3 VCAN	2.28e-05	184	204	7	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRSS22 C3 MPP3 NTN4 SHANK2 FAM13A LMO7	2.28e-05	184	204	7	ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCell	Control-Epithelial_alveolar-AT_2-AT2_Progenitor\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRSS22 BMP3 C3 MPP3 NTN4 SHANK2 LMO7	2.36e-05	185	204	7	8ca1374501eca01d8468130b74d50abfd4329fbe
ToppCell	Control-Epithelial_alveolar\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRSS22 C3 MPP3 DENND3 NTN4 SHANK2 LMO7	2.36e-05	185	204	7	3937e026add96a396122139daf8011cfbc60e75c
Drug	W-Mo	MEA1 TAC1 TNC FUT3	7.61e-07	9	204	4	CID000008364
Drug	rofecoxib	STAT3 COLEC12 C3 TAC1 FLNB TNC LIFR VCAN EPHA3	8.33e-07	113	204	9	ctd:C116926
Drug	0179445-0000 [211246-22-9]; Down 200; 1uM; PC3; HT_HG-U133A	INPP4A SPTBN2 JAG2 FASN SSH3 ZER1 GALNT14 RBM42 FAM13A ZNF667 TGS1	1.66e-06	196	204	11	4292_DN
Drug	Cefazolin sodium salt [27164-46-1]; Down 200; 8.4uM; PC3; HT_HG-U133A	INPP4A SPTBN2 ADCY9 PHC3 SSH3 ZER1 NLRP1 CHD7 LMO7 ZNF667 ALOXE3	1.66e-06	196	204	11	3686_DN
Drug	Flavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; HL60; HT_HG-U133A	PPP1R15A ADCY9 SSH3 PLD1 IL27RA FLNB ANGEL1 KLF1 VCAN ZNF747 DHX34	1.66e-06	196	204	11	2373_DN
Disease	CHARGE syndrome (implicated_via_orthology)	CHD6 CHD9 CHD8 CHD7	6.51e-08	7	196	4	DOID:0050834 (implicated_via_orthology)
Disease	Profound Mental Retardation	STAG1 INPP4A FASN CHD8 GRIN2B RGS7 SHANK2	4.18e-05	139	196	7	C0020796
Disease	Mental Retardation, Psychosocial	STAG1 INPP4A FASN CHD8 GRIN2B RGS7 SHANK2	4.18e-05	139	196	7	C0025363
Disease	Mental deficiency	STAG1 INPP4A FASN CHD8 GRIN2B RGS7 SHANK2	4.18e-05	139	196	7	C0917816
Disease	testosterone measurement	PDE4B STAG1 ZNF785 ADCY9 TYK2 FASN ZNF394 BPGM ANAPC1 MINAR1 USH2A BRWD1 NRDE2 ADAMTS3 TMPRSS11E PSD3 CHD7 C2CD2 LIPE RGS6 MYOCD RPE65	4.34e-05	1275	196	22	EFO_0004908
Disease	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	ALOX12B ALOXE3	4.39e-05	2	196	2	242100
Disease	Autosomal recessive congenital ichthyosis 2	ALOX12B ALOXE3	4.39e-05	2	196	2	cv:C3888093
Disease	ICHTHYOSIFORM ERYTHRODERMA, CONGENITAL, NONBULLOUS, 1	ALOX12B ALOXE3	4.39e-05	2	196	2	C1855792
Disease	cholesteryl ester 18:0 measurement	NPC1L1 NECTIN2 WSCD1 NLRP1	9.42e-05	36	196	4	EFO_0010343
Disease	triglyceride measurement, low density lipoprotein cholesterol measurement	TDRD15 STAT3 MAP4K2 BRWD1 MPP3 TMPRSS11E PSD3	1.28e-04	166	196	7	EFO_0004530, EFO_0004611
Disease	myofibrillar myopathy 5 (implicated_via_orthology)	FLNA FLNB	1.31e-04	3	196	2	DOID:0080096 (implicated_via_orthology)
Disease	distal muscular dystrophy 4 (implicated_via_orthology)	FLNA FLNB	1.31e-04	3	196	2	DOID:0111190 (implicated_via_orthology)
Disease	Self-Healing Collodion Baby	ALOX12B ALOXE3	1.31e-04	3	196	2	C1855789
Disease	Disproportionate short stature	EXT2 EIF2AK3 FLNA FLNB LIFR	1.65e-04	77	196	5	C0878659
Disease	myeloid white cell count	USP34 MYO1E PPCDC JAG2 FAP BPGM FCGR2B PKD1 C3 SERTAD1 SLC25A24 FLNB CHD7 CRK FAM13A CNEP1R1 TGS1	1.86e-04	937	196	17	EFO_0007988
Disease	osteochondrodysplasia (is_implicated_in)	FLNA FLNB LIFR	2.59e-04	19	196	3	DOID:2256 (is_implicated_in)
Disease	Ichthyosis Congenita I	ALOX12B ALOXE3	2.61e-04	4	196	2	C4551630
Disease	Harlequin Fetus	ALOX12B ALOXE3	2.61e-04	4	196	2	C0239849
Disease	Ichthyosis Congenita II	ALOX12B ALOXE3	2.61e-04	4	196	2	C3536797
Disease	Collodion Fetus	ALOX12B ALOXE3	2.61e-04	4	196	2	C3543867
Disease	Congenital ichthyosis	ALOX12B ALOXE3	4.33e-04	5	196	2	C0020758
Disease	complex trait	TDRD15 ZNF785 FREM1 NECTIN2 CHD6 MAP4K2 ZNF689 PSD3	4.83e-04	271	196	8	EFO_0010578
Disease	low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	TDRD15 CILP2 FCGR2B NECTIN2 TMPRSS11E PSD3	5.72e-04	153	196	6	EFO_0004611, EFO_0020946
Disease	prostate cancer (is_marker_for)	KDM3A CBX3 HNRNPK CBX1 TIMP2 KDM4A	6.33e-04	156	196	6	DOID:10283 (is_marker_for)
Disease	pappalysin-1 measurement	USP34 CHD7	6.47e-04	6	196	2	EFO_0802845
Disease	Idiopathic Membranous Glomerulonephritis	C3 GAA	6.47e-04	6	196	2	C0086445
Disease	Heymann Nephritis	C3 GAA	6.47e-04	6	196	2	C1704378
Disease	Membranous glomerulonephritis	C3 GAA	6.47e-04	6	196	2	C0017665
Disease	fear of pain measurement	TRMT12 MYOCD	6.47e-04	6	196	2	EFO_0008330
Disease	cortical surface area measurement	USP34 STAG1 SKIDA1 JAG2 COLEC12 BPGM RAB3GAP2 PKD1 TICRR FLNB ADAMTS3 CPSF6 CHD7 DENND3 NTN4 FAM13A VCAN ARHGAP12 PAPPA EPHA3	6.71e-04	1345	196	20	EFO_0010736
Disease	cholesterol in chylomicrons and extremely large VLDL measurement	STAG1 EHMT2 NECTIN2 PSD3	6.88e-04	60	196	4	EFO_0021898
Disease	free cholesterol in chylomicrons and extremely large VLDL measurement	STAG1 EHMT2 NECTIN2 PSD3	7.79e-04	62	196	4	EFO_0022263
Disease	Ciliopathies	SCNN1B USH2A PCARE WDPCP RPE65	8.56e-04	110	196	5	C4277690
Disease	Common Migraine	TAC1 TRPM8	9.02e-04	7	196	2	C0338480
Disease	respiratory failure, COVID-19	FREM1 TYK2 DST	9.29e-04	29	196	3	EFO_0009686, MONDO_0100096
Disease	congenital heart disease (implicated_via_orthology)	CHD6 CHD9 CHD8 CHD7	1.17e-03	69	196	4	DOID:1682 (implicated_via_orthology)
Disease	mean corpuscular hemoglobin concentration	PPCDC PPP1R15A ADCY9 STAT3 COLEC12 BNIP3L FCGR2B NECTIN2 TICRR ITSN1 PSD3 WDHD1 INSL6 KLF1 PRKDC ENO2 GAA	1.19e-03	1105	196	17	EFO_0004528
Disease	serum gamma-glutamyl transferase measurement	STAG1 FCGR2B NECTIN2 PKD1 ZER1 C3 WSCD1 CPSF6 TMPRSS11E PSD3 CHD9 NLRP1 FCGR2C ZNF747 FUT3	1.23e-03	914	196	15	EFO_0004532
Disease	level of Sphingomyelin (d40:1) in blood serum	WSCD1 ADAMTS3 NLRP1	1.24e-03	32	196	3	OBA_2045182
Disease	low density lipoprotein cholesterol measurement, phospholipid measurement	TDRD15 ADAM21 NPC1L1 NECTIN2 BRWD1	1.26e-03	120	196	5	EFO_0004611, EFO_0004639
Disease	FEV/FEC ratio	USP34 DZIP1L ZNF184 SKIDA1 MRPS35 DST FCGR2B ANAPC1 MRC2 TRPM8 TRMT61B ZKSCAN2 DENND3 NTN4 FCGR2C FAM13A TIMP2 ARHGAP12	1.46e-03	1228	196	18	EFO_0004713
Disease	Middle Cerebral Artery Embolus	STAT3 C3 PLD1	1.48e-03	34	196	3	C0751845
Disease	Embolic Infarction, Middle Cerebral Artery	STAT3 C3 PLD1	1.48e-03	34	196	3	C0751847
Disease	Left Middle Cerebral Artery Infarction	STAT3 C3 PLD1	1.48e-03	34	196	3	C0751846
Disease	Right Middle Cerebral Artery Infarction	STAT3 C3 PLD1	1.48e-03	34	196	3	C0751849
Disease	Thrombotic Infarction, Middle Cerebral Artery	STAT3 C3 PLD1	1.48e-03	34	196	3	C0751848
Disease	Middle Cerebral Artery Occlusion	STAT3 C3 PLD1	1.48e-03	34	196	3	C0740391
Disease	Infarction, Middle Cerebral Artery	STAT3 C3 PLD1	1.48e-03	34	196	3	C0740392
Disease	Middle Cerebral Artery Thrombosis	STAT3 C3 PLD1	1.48e-03	34	196	3	C0740376
Disease	Middle Cerebral Artery Syndrome	STAT3 C3 PLD1	1.48e-03	34	196	3	C0238281
Disease	Acute Myeloid Leukemia, M1	PDE4B STAT3 EHMT2 NECTIN2 ENO2	1.51e-03	125	196	5	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	PDE4B STAT3 EHMT2 NECTIN2 ENO2	1.51e-03	125	196	5	C1879321
Disease	underweight body mass index status	ADGRB3 RGS6	1.53e-03	9	196	2	EFO_0005936
Disease	malaria (implicated_via_orthology)	FCGR2B FCGR2C	1.53e-03	9	196	2	DOID:12365 (implicated_via_orthology)
Disease	infection	ZNF785 ZNF689	1.53e-03	9	196	2	EFO_0000544
Disease	interferon alpha/beta receptor 1 measurement	TYK2 ITSN1	1.53e-03	9	196	2	EFO_0021850
Disease	plexin-B2 measurement	FCGR2B FCGR2C	1.53e-03	9	196	2	EFO_0021867
Disease	HMG CoA reductase inhibitor use measurement	TDRD15 STAG1 NPC1L1 NECTIN2 TMPRSS11E PSD3	1.70e-03	189	196	6	EFO_0009932
Disease	lymphocyte percentage of leukocytes	ADCY9 TYK2 FASN BNIP3L IL27RA SERTAD1 CAMK4 CHD7 CRK SCML4 KLF1 PRKDC	1.73e-03	665	196	12	EFO_0007993
Disease	lymphocyte count	PPCDC ADCY9 HNRNPK TYK2 FAP CILP2 BPGM ANAPC1 NECTIN2 C3 IL27RA FLNB CAMK4 ZNF689 PSD3 CHD7 DENND3 SCML4 KYAT3 PAPPA	1.86e-03	1464	196	20	EFO_0004587
Disease	alopecia areata (is_marker_for)	EHMT2 KDM4A	1.91e-03	10	196	2	DOID:986 (is_marker_for)
Disease	Pleural Diseases	TNC TIMP2	1.91e-03	10	196	2	C0032226
Disease	Alzheimer's disease (is_implicated_in)	MAOB STAT3 NECTIN2 C3 GRIN2B	1.92e-03	132	196	5	DOID:10652 (is_implicated_in)
Disease	neuroimaging measurement	STAG1 SKIDA1 TYK2 JAG2 BPGM RAB3GAP2 PKD1 PLD1 EIF2AK3 ADAMTS3 CHD7 DENND3 VCAN ARHGAP12 PAPPA EPHA3	2.17e-03	1069	196	16	EFO_0004346
Disease	Congenital Nonbullous Ichthyosiform Erythroderma	ALOX12B ALOXE3	2.32e-03	11	196	2	C0079154
Disease	motor function measurement	ADAM21 CAMK4	2.32e-03	11	196	2	EFO_0010749
Disease	Congenital ichthyosis of skin	ALOX12B ALOXE3	2.32e-03	11	196	2	cv:C0020758
Disease	triglyceride measurement, high density lipoprotein cholesterol measurement	TDRD15 STAG1 NECTIN2 MAP4K2 TMPRSS11E PSD3 DNAH1	2.47e-03	274	196	7	EFO_0004530, EFO_0004612
Disease	Autism Spectrum Disorders	USH2A CHD8 GRIN2B DDHD1	2.51e-03	85	196	4	C1510586
Disease	migraine disorder, Headache	GPR149 TRPM8 PAPPA WDR12	2.62e-03	86	196	4	HP_0002315, MONDO_0005277
Disease	intracranial aneurysm (is_implicated_in)	PKD1 VCAN	2.77e-03	12	196	2	DOID:10941 (is_implicated_in)
Disease	migraine disorder	EHMT2 MRC2 GPR149 TRPM8 WSCD1 NLRP1 PAPPA WDR12	2.78e-03	357	196	8	MONDO_0005277
Disease	Prostatic Neoplasms	STAT3 NECTIN2 CBX1 CHD6 ALOX12B ITSN1 CHD7 LIFR FBXO44 ALOXE3 PRKDC	2.89e-03	616	196	11	C0033578
Disease	Malignant neoplasm of prostate	STAT3 NECTIN2 CBX1 CHD6 ALOX12B ITSN1 CHD7 LIFR FBXO44 ALOXE3 PRKDC	2.89e-03	616	196	11	C0376358
Disease	Disorder of eye	FREM1 USH2A PCARE WDPCP VCAN RPE65	3.02e-03	212	196	6	C0015397
Disease	non-high density lipoprotein cholesterol measurement	USP34 TDRD15 STAT3 TYK2 NPC1L1 ZNF579 BRWD1 ADAMTS3 PSD3 CHD7 WDPCP FUT3	3.05e-03	713	196	12	EFO_0005689
Disease	neutrophil count, eosinophil count	MYO1E FCGR2B SLC25A24 CHD7 CRK TGS1	3.09e-03	213	196	6	EFO_0004833, EFO_0004842
Disease	Fulminant Hepatic Failure with Cerebral Edema	MAOB PRKDC	3.26e-03	13	196	2	C0751197
Disease	Hepatic Stupor	MAOB PRKDC	3.26e-03	13	196	2	C0751198
Disease	Hepatic Encephalopathy	MAOB PRKDC	3.26e-03	13	196	2	C0019151
Disease	Hepatic Coma	MAOB PRKDC	3.26e-03	13	196	2	C0019147
Disease	androstenediol (3alpha, 17alpha) monosulfate (3) measurement	ZNF394 TMPRSS11E	3.26e-03	13	196	2	EFO_0800293
Disease	alkaline phosphatase measurement	USP34 TDRD15 PHEX CILP2 NWD2 FCGR2B NECTIN2 PKD1 MAP4K2 ZNF689 TMPRSS11E PSD3 FCGR2C RGS6 FUT3	3.34e-03	1015	196	15	EFO_0004533
Disease	autism spectrum disorder (implicated_via_orthology)	CHD6 CHD9 CHD8 CHD7 SHANK2	3.54e-03	152	196	5	DOID:0060041 (implicated_via_orthology)
Disease	anxiety, stress-related disorder, major depressive disorder	PDE4B ZNF184 ZKSCAN2	3.55e-03	46	196	3	EFO_0005230, EFO_0010098, MONDO_0002009
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	TDRD15 NPC1L1 BRWD1 MPP3 TMPRSS11E PSD3	3.62e-03	220	196	6	EFO_0004529, EFO_0008317
Disease	fibrinogen measurement, coronary artery disease	TDRD15 STAG1 GPR149 CHD9 WDR12	3.74e-03	154	196	5	EFO_0001645, EFO_0004623
Disease	5alpha-androstan-3alpha,17alpha-diol monosulfate measurement	ZNF394 TMPRSS11E	3.79e-03	14	196	2	EFO_0800283
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	TDRD15 ADAMTS3	3.79e-03	14	196	2	EFO_0004611, EFO_0008589
Disease	lipid measurement, intermediate density lipoprotein measurement	TDRD15 NPC1L1 NECTIN2 TMPRSS11E	3.90e-03	96	196	4	EFO_0004529, EFO_0008595
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	TDRD15 STAT3 MAP4K2 MPP3 PSD3 DNAH1	3.95e-03	224	196	6	EFO_0004530, EFO_0008317
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	TDRD15 NPC1L1 NECTIN2 MPP3 TMPRSS11E PSD3	3.95e-03	224	196	6	EFO_0004574, EFO_0008317
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	TDRD15 NPC1L1 NECTIN2 MPP3 TMPRSS11E PSD3	4.04e-03	225	196	6	EFO_0008317, EFO_0010351
Disease	phospholipid measurement, intermediate density lipoprotein measurement	TDRD15 NPC1L1 NECTIN2 TMPRSS11E	4.35e-03	99	196	4	EFO_0004639, EFO_0008595
Disease	Alzheimer disease, peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease	PDE4B NECTIN2	4.35e-03	15	196	2	EFO_0003948, EFO_0009923, MONDO_0004247, MONDO_0004975
Disease	very low density lipoprotein cholesterol measurement, phospholipid measurement	TDRD15 NPC1L1 BRWD1 MPP3 TMPRSS11E PSD3	4.40e-03	229	196	6	EFO_0004639, EFO_0008317
Disease	Endometrioma	MAOB SMPDL3A TNC VCAN PAPPA	4.51e-03	161	196	5	C0269102
Disease	Endometriosis	MAOB SMPDL3A TNC VCAN PAPPA	4.51e-03	161	196	5	C0014175
Disease	diet measurement	TDRD15 TCAF1 PDE4B SKIDA1 ADGRB3 TMEM260 NWD2 DST ZNF394 NECTIN2 CHD6 ZKSCAN2 RGS7 WDPCP PRKDC	4.52e-03	1049	196	15	EFO_0008111
Disease	opioid use disorder	PDE4B ZNF184 PPP6C KDM4A	4.67e-03	101	196	4	EFO_0010702

Protein segments in the cluster

Peptide	Gene	Start	Entry
DIGWSEWIISPKSFD	BMP3	381	P12645
GEEWKQPESDLWLIE	C4orf33	181	Q8N1A6
DQLEVPTTWWDSEAD	CHD8	1616	Q9HCK8
PTTWWDSEADKSLLI	CHD8	1621	Q9HCK8
EAATVSKWSWDEDNT	VCAN	796	P13611
ALQWLDPSEDLTWLE	C2orf80	51	Q0P641
DPSEDLTWLEWEELK	C2orf80	56	Q0P641
WKGFTDADNTWEPEE	CBX3	51	Q13185
DEIWLKDESTDWPLS	EIF2AK3	671	Q9NZJ5
PLWPEWSEADINSEK	ADGB	46	Q8N7X0
LWDDSKTNESLGTWS	ADGRB3	821	O60242
ENSALEPKSAGDWWT	ADAM21	191	Q9UKJ8
VVEEWVKETHADLWP	COPB2	806	P35606
ATESDWADCKSPQPW	FCGR2B	11	P31994
EFPESWLWNVEDLKE	C3	766	P01024
TAWDLTPERSDVWFA	EHMT2	886	Q96KQ7
ALWEDKTSLWEEENA	CCDC70	176	Q6NSX1
KTSLWEEENALWEEE	CCDC70	181	Q6NSX1
WEWEEDPASIEPISS	CFAP92	6	Q9ULG3
WKETEAEAQEVSLPW	DENND3	696	A2RUS2
TDISLDDPNFWQKWA	CHD7	1521	Q9P2D1
SIEDPFDQDDWAAWS	ENO2	291	P09104
EGFITKDWDQPVADW	FBXO6	61	Q9NRD1
WESQWSKTSQPEDLT	ARMC10	71	Q8N2F6
IRDKPEEQWWNAEDS	CRK	161	P46108
WGVEEDEWDSPELQK	NWD2	86	Q9ULI1
VPKQTDVEEWTSWDE	EBAG9	51	O00559
DVEEWTSWDEDAPTS	EBAG9	56	O00559
SSWEDPSLLEWDADD	RBM42	366	Q9BTD8
SNPWISDDVALWDIE	RGS6	306	P49758
SSLQVDWHEEEWEKV	INPP4A	516	Q96PE3
WSAKEPSDSWLIASL	MAMDC2	116	Q7Z304
PWEEEWTLLGKEELS	MAP4K2	351	Q12851
WDDILPNSKWVDSNV	ANAPC1	1416	Q9H1A4
SDAPWKAPLAEEWDN	MAOB	131	P27338
VPRPKDDWDWSDTET	DZIP1L	641	Q8IYY4
VAIDETWDSQSVSPW	RAB3GAP2	806	Q9H2M9
SEKEDATIWWPLSDP	PADI6	66	Q6TGC4
STLRWEPSQEDWEEM	KLHL33	291	A6NCF5
EEPWSWPEEYNKALE	MAGEE2	276	Q8TD90
EWLAVADTSKEEWFT	LRIT2	381	A6NDA9
FISPWWDEVSLNAKD	CAMK4	261	Q16566
WLQWAETTLTDKDKE	DST	7046	Q03001
DWDKDLWEQTSTPFV	GTSF1	106	Q8WW33
VEAWDWDNDTTPNEE	JAG2	146	Q9Y219
PTDSEWDWLLAKTWV	ALOXE3	381	Q9BYJ1
WSGVKEEPSKDWERS	PPFIA3	546	O75145
VANLWKPWLDEEAIS	SMPDL3A	171	Q92484
PNIAFWTEAQKIWED	KIAA1109	4686	Q2LD37
IEAFETWRSWADPKV	DPYS	111	Q14117
PTELDQVRKWISDWN	EIF3M	141	Q7L2H7
STDSEWPWIVSIQKN	PRSS22	56	Q9GZN4
FDEGKWSTPEAWADD	MPPE1	121	Q53F39
ATESDWADCKSPQPW	FCGR2C	11	P31995
WESWDPQKPVDNARE	FLNB	186	O75369
LWETWADLVQPDAQD	PDE4B	626	Q07343
ESLCSTWPWKNEDFN	NLRP1	261	Q9C000
SERENEWKWLDGTSP	COLEC12	671	Q5KU26
FITEDWDQPVADWKI	FBXO44	56	Q9H4M3
IAWKAWSPQTKDVED	FREM1	2036	Q5H8C1
CTEFWEPSTLVKEWQ	NRDE2	391	Q9H7Z3
EKEEDLWGEWSPILS	IL27RA	211	Q6UWB1
IEENLEPWPQAWDDS	PGM2	196	Q96G03
EPWPQAWDDSLIDSS	PGM2	201	Q96G03
EETEAWAKPLSQLWQ	KDM4A	631	O75164
TISAPSRWVWDQEEE	LMO7	1216	Q8WWI1
TREPSLATWEATWSE	LMO7	1291	Q8WWI1
WSDNSPLKYLNWESD	MRC2	311	Q9UBG0
LEELGQEWVPVESSW	BPGM	71	P07738
SEEELAGVATWPWDK	PAPPA	521	Q13219
EKNWEEPIPAFSSWQ	FAM13A	571	O94988
VAQTEPSIWTVDDVW	PHC3	911	Q8NDX5
SFTESPWETMEWLDL	MYOCD	881	Q8IZQ8
TNDDWWQVKPDENSK	ARHGAP12	46	Q8IWW6
TPKPSDADWDDLWDQ	GALNT14	41	Q96FL9
SHEESQKPDLSDWEW	GPR149	516	Q86SP6
LAIPASSWVDDFIDW	NPC1L1	946	Q9UHC9
NDDAWPWAPISSEKD	WDPCP	246	O95876
WSESWMNDPLSAIDA	DNAH1	1036	Q9P2D7
WFNEWPAEALKSVAT	DNAH1	2741	Q9P2D7
QEELDTFEWALKSWS	ADAMTS3	841	O15072
PAEWWDFDADKSLLI	CHD9	1671	Q3L8U1
PDTQDDFLKWWRSEE	KLF1	21	Q13351
DSWDVERVAEWPWLS	KDM3A	31	Q9Y4C1
SWDLEKEPQAAAWSS	C2CD2	581	Q9Y426
GNLTWWTTDEDLTEA	CPSF6	86	Q16630
EKIWEVLGVPTEDTW	CDK15	311	Q96Q40
EIPVDWWDAEADKSL	CHD6	1271	Q8TD26
PDWDSWDASKPVTNA	FLNA	211	P21333
TWPTSTNEKPETDNW	ITSN1	856	Q15811
TNEKPETDNWDAWAA	ITSN1	861	Q15811
ETDNWDAWAAQPSLT	ITSN1	866	Q15811
KSADWVSDWSSRPEN	BNIP3L	136	O60238
KWKGFSDEDNTWEPE	CBX1	41	P83916
ASSRWWDPKFDSVNL	ADCY9	86	O60503
INETSVILDWSWPLD	EPHA3	336	P29320
VRWDNTEIEKLSPWD	BRWD1	1106	Q9NSI6
QWWAIDDIVKTSVPS	FAM169A	86	Q9Y6X4
DVWSSWEQLASSVPE	GAA	616	P10253
PSDSEWDWLLAKTWV	ALOX12B	371	O75342
SIEDPFDQDDWATWT	ENO3	291	P13929
WFIDGTWQPLEEEES	DDHD1	291	Q8NEL9
EVVEVLDSSNPSWWT	GRAP2	296	O75791
DFLWDVPSNWTLEEA	FASN	1631	P49327
KEESPVVSWWLEPED	BAGE4	21	Q86Y28
EEEALEKWDWNCPET	DHX34	21	Q14147
KEDGEPSWREAKVSW	PWWP2B	516	Q6NUJ5
TWGPEDEELWRKLSF	SCAP	616	Q12770
TISMADWPSEASEDW	SCNN1B	456	P51168
REQSTLESEEWNPWE	RXYLT1	56	Q9Y2B1
LESEEWNPWEGDEKN	RXYLT1	61	Q9Y2B1
KRWSSSDWTLDPQEL	KYAT3	186	Q6YP21
GLEEWSDWSPVKNIS	LIFR	231	P42702
EWKALSEWVTDSESE	LIPE	221	Q05469
SWWCQPSDEEEGEVK	PPP1R15A	301	O75807
TWSLEEGLSWETSEP	PKD1	1751	P98161
WDLAPEPEEWKSVTS	PCARE	371	A6NGG8
VQPPALWQTEKDDWT	IL4I1	456	Q96RQ9
EVVSQDDPTWWQAKR	MPP3	261	Q13368
QTPWPAKSWSLNTEE	MINAR1	361	Q9UPX6
SSSPKNSEDLRWKWA	MROH5	361	Q6ZUA9
PAWAREISDAQWEDV	MEA1	156	Q16626
SGSEDESVKTPWFWA	GPRASP1	251	Q5JY77
RPEEEEDIVNSWFWS	GPRASP1	696	Q5JY77
SWFWKEDEAISEATD	GPRASP1	751	Q5JY77
VIIGSWFWEEEASPE	GPRASP1	841	Q5JY77
EEITVGSWFWPEEEA	GPRASP1	871	Q5JY77
ELVAWAVSNWKPDSA	FUT3	191	P21217
HESWNTEEWEKSKTE	MRPS35	231	P82673
AIWEPLDWQSSEEQI	USH2A	1686	O75445
WLSDDTTFWELEASK	RGS7	306	P49802
NVKTKETWVWQEPDS	RPE65	451	Q16518
DWREETLWKTKQPEA	TRMT44	691	Q8IYL2
SGVKWNEPDEIWDDK	TDRD15	1411	B5MCY1
EAWAWPIQKEVATSL	TCAF1	886	Q9Y4C2
EEDSKTWPWGLDRQF	FER1L5	1036	A0AVI2
PEVDDSSAQKGWWFL	GGTA1	41	Q4G0N0
VHNKSEPAWEWEDAQ	NTN4	481	Q9HB63
EANEEIFITDWWLSP	PLD1	371	Q13393
PVSTSWEEAVNSWEM	INSL6	96	Q9Y581
WEEAVNSWEMQSLPE	INSL6	101	Q9Y581
ADETWDSAIDTWSPS	HNRNPK	341	P61978
DSAIDTWSPSEWQMA	HNRNPK	346	P61978
TSDDKSLRVWEWDIP	CDC40	436	O60508
QAPEVAKSWAALASW	SMG1	1611	Q96Q15
SVKAESPAEWNLQSW	SKIDA1	511	Q1XH10
KEWDITTLNPFWNVS	SPATA31E1	396	Q6ZUB1
ESPNKEDDTQWLTYW	REEP5	76	Q00765
EEEEEKEPLAVDSWW	SERTAD1	11	Q9UHV2
AWNWLIDPETQKVSF	CNEP1R1	46	Q8N9A8
WTKPDVADWLESLNL	SHANK2	1786	Q9UPX8
WDEESAQLLPHWKET	SSH3	381	Q8TE77
TEQWEEDPAVLAWSI	ANGEL1	171	Q9UNK9
PSPALEDWEEASEWT	CILP2	46	Q8IUL8
LWSLNPETGLWEEES	CILP2	681	Q8IUL8
RTASSWEEDWFAKIP	CHST12	371	Q9NRB3
EGDWSWVDDTPFNKV	CD207	261	Q9UJ71
SDADEWEIWKSRSDP	PPCDC	71	Q96CD2
DWQTWDCPKTQEHIE	FAP	326	Q12884
EEWEWLSPIQKDLYE	ZNF667	26	Q5HYK9
TEVEEGEWPWQASLQ	TMPRSS11E	196	Q9UL52
DFTWEEWQFLSPAQK	ZNF615	16	Q8N8J6
QMWSVWDKNAPDEDS	AVPR1B	301	P47901
AVSLTWEEWERLDPA	ZNF394	161	Q53GI3
EEREWPESVSLDWET	ZNF2	81	Q9BSG1
FSWSALWNITDETPD	ZER1	546	Q7Z7L7
VDTTEWSKLWESPDH	TICRR	211	Q7Z2Z1
DSWKLSHVEEWPDNV	TRMT61B	296	Q9BVS5
EEDSWGSESKLWEKD	ZSCAN20	26	P17040
WDLPDSDWDNDSSSA	SPTBN2	26	O15020
DWVTENTATVSWDPV	TNN	806	Q9UQP3
WSDPEDVDTWAISPR	PPP6C	196	O00743
PWIESQDWAYAASKE	STAT3	36	P40763
FSSWDSSKEWIIDLP	WDHD1	516	O75717
WELEDQSAVDWTQEP	WDR97	1131	A6NE52
ISWVEEKAELWDPAA	ZNF747	86	Q9BV97
WPHSIESSNDWNVEK	EXT2	46	Q93063
EVSWDALRLNWTTPD	TNC	1266	P24821
ISSPDECLWMDWVTE	TIMP2	166	P16035
DSLAETFWETTKWTD	TPP2	1161	P29144
VEEVNWASWEQTLPT	TRPV2	706	Q9Y5S1
NGNLDPWWSTESEEK	PHEX	596	P78562
DSLWESSQELLKDWE	STAG1	486	Q8WVM7
PWVLSEAEDLEKSWL	TTC21A	1191	Q8NDW8
WVDGEPTEAEKDFWE	PRKDC	2981	P78527
SWMEQESEAWSPAAQ	ZNF688	76	P0C7X2
ALISWLERNTDDWEP	ZNF689	76	Q96CS4
SDVTVSWSPEEAEAW	ZNF213	266	O14771
SWSPEEAEAWESENR	ZNF213	271	O14771
WVPALADEWNTLDQE	ZKSCAN2	201	Q63HK3
PATKPEWQRWAESAE	TRMT12	386	Q53H54
LEPKEQESWTVWQLD	USP34	1506	Q70CQ2
ASNPEDTWDSKTWLQ	VWA3B	381	Q502W6
EPWNFPDTKEEWEQH	TGS1	226	Q96RS0
DDWISSIKGAEEWIL	WDR12	101	Q9GZL7
ADRNWKSKEWPDFVN	WSCD1	451	Q658N2
KQFTEDWSEEDVSTW	WDSUB1	326	Q8N9V3
VSRLPEEETESWIKW	TRPM8	366	Q7Z2W7
WETLWAEEEEEGSSP	ZDHHC12	251	Q96GR4
AGPIEQKEARWESSW	TMIGD3	6	P0DMS9
QKEARWESSWEEQPD	TMIGD3	11	P0DMS9
ATEEEAVAAWPETWP	ZNF579	161	Q8NAF0
WSDWYDSDQIKEELP	TAC1	31	P20366
DEDQRSDLKWQWEPE	TCHH	1216	Q07283
SDLKWQWEPEKENAV	TCHH	1221	Q07283
LTENVWDESWKAPSE	PSD3	356	Q9NYI0
FTQLEDDEQSWVPSW	ZNF584	66	Q8IVC4
DDEQSWVPSWVDVTP	ZNF584	71	Q8IVC4
WTVEDVVWFVKDADP	SCML4	346	Q8N228
PDEFTEDEKKSGQWW	SLC25A24	181	Q6NUK1
SISWDPEDFEDAWKR	TLE6	246	Q9H808
EVAHEVAVKEWWPSV	ZNF785	131	A8K8V0
KRDDSWSSNLLESWE	ZNF184	131	Q99676
PDWESRWENKELSTK	ZNF181	76	Q2M3W8
FDPSSWESVANEEMW	TMEM260	576	Q9NX78
KPALISWVEEEAELW	ZNF764	71	Q96H86
WWPVEEEVNKEEGSS	TYK2	326	P29597
DFTWEEWQFLSPAQK	ZNF649	16	Q9BS31
LDFSQEEWEWLKPSQ	ZNF527	21	Q8NB42
DWESWCEIEELSPKW	ZNF527	86	Q8NB42
WIEEKGTPQASCSDW	ZNF554	136	Q86TJ5
AELLETWDNISWPKD	NLRP13	186	Q86W25
DIIDIIKEDPSGWWT	MYO1E	1076	Q12965
ESWEAAQETWEDKRR	ART5	66	Q96L15
DWWEENCVPGHDKVT	NAPEPLD	231	Q6IQ20
PWEKNLTNVEWEDRS	GRIN2B	1196	Q13224
WLSSLDWEAKETQVS	NECTIN2	196	Q92692
ALQTSDWIRVDPWES	NMNAT3	71	Q96T66